Search research articles
Contact Us
Filters
Showing results (391-400 of 426) with videos related to
Page
of 43
Sort By:
Chemical Research in Toxicology
|
October 16, 2007
A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif
Amit S Kalgutkar, James Driscoll, Sabrina X Zhao, et al.
Klinische Padiatrie
|
May 24, 2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000
M Schrappe, A Möricke, A Reiter, et al.
Leukemia
|
December 19, 2017
Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
B Peter, S Bibi, G Eisenwort, et al.
Bone Marrow Transplantation
|
May 1, 1996
Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group
R Hehlmann, H Heimpel, D K Hossfeld, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor
L A Reiter, K Koch, A D Piscopio, et al.
Frontiers in Neuroinformatics
|
February 13, 2016
Using Make for Reproducible and Parallel Neuroimaging Workflow and Quality-Assurance
Mary K Askren, Trevor K McAllister-Day, Natalie Koh, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666
Kenneth W Duncan, Nathalie Rioux, P Ann Boriack-Sjodin, et al.
Nature
|
April 10, 2020
Author Correction: Complete biosynthesis of cannabinoids and their unnatural analogues in yeast
Xiaozhou Luo, Michael A Reiter, Leo d'Espaux, et al.
Nature
|
March 1, 2019
Complete biosynthesis of cannabinoids and their unnatural analogues in yeast
Xiaozhou Luo, Michael A Reiter, Leo d'Espaux, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 17, 1998
The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543
H J Showell, M J Conklyn, R Alpert, et al.
Page
of 43
Search research articles
Search
Showing results (391-400 of 426) with videos related to
Sort By:
Page
of 43
Chemical Research in Toxicology
|
October 16, 2007
A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif
Amit S Kalgutkar, James Driscoll, Sabrina X Zhao, et al.
Klinische Padiatrie
|
May 24, 2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000
M Schrappe, A Möricke, A Reiter, et al.
Leukemia
|
December 19, 2017
Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
B Peter, S Bibi, G Eisenwort, et al.
Bone Marrow Transplantation
|
May 1, 1996
Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group
R Hehlmann, H Heimpel, D K Hossfeld, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor
L A Reiter, K Koch, A D Piscopio, et al.
Frontiers in Neuroinformatics
|
February 13, 2016
Using Make for Reproducible and Parallel Neuroimaging Workflow and Quality-Assurance
Mary K Askren, Trevor K McAllister-Day, Natalie Koh, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666
Kenneth W Duncan, Nathalie Rioux, P Ann Boriack-Sjodin, et al.
Nature
|
April 10, 2020
Author Correction: Complete biosynthesis of cannabinoids and their unnatural analogues in yeast
Xiaozhou Luo, Michael A Reiter, Leo d'Espaux, et al.
Nature
|
March 1, 2019
Complete biosynthesis of cannabinoids and their unnatural analogues in yeast
Xiaozhou Luo, Michael A Reiter, Leo d'Espaux, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 17, 1998
The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543
H J Showell, M J Conklyn, R Alpert, et al.
Page
of 43